Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01155817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01155817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2010
Completion date
December 31, 2013
Enrollment
33 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant failure, lymphoma, non-hodgkin, lymphoma, t-cell, peripheral